Popular on s4story
- New Memoir Takes Readers Along on a Post-Retirement Travel Journey - 178
- Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd - 172
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 140
- Local Independent Author Releases Southern Gothic Novel Where The Land Remembers - 120
- PricZone Launches Online Shopping Platform Offering Electronics, Gaming, and More
- Ignazio Arces Wins Stevie® Award for Maverick of the Year at the 2026 International Business Awards
- Akiti the Hunter Launches Mission to Deliver One Million Books to One Million Children Worldwide
- Intuitive Numerologist, Yvonne Sullivan, Publishes the Ultimate Guide to the NOC Divination System
- Picaboo Helps Family Recover 16 Years of Memories After Devastating House Fire
- Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
Similar on s4story
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
- Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing
- Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering
- Steve Thompson Launches StickyHealth to Tackle the Retention Gap in the Growing GLP 1 Market
- Qscription Technologies Appoints Dr. Kimberly Beavers as Founding Clinical Advisor
Applications Now Open for the 2027 BrightEdge Entrepreneurs Program
S For Story/10702202
BrightEdge, the American Cancer Society's Innovation and Impact Investment Arm, and ScaleHealth Open Applications for the 2027 BrightEdge Entrepreneurs Program
LOS ANGELES - s4story -- The dual-track program will provide cancer-focused innovators with investment, expert mentorship, education, and access to national healthcare networks
BrightEdge, the impact investment and innovation arm of the American Cancer Society (ACS), is proud to announce the opening of applications for the 2027 BrightEdge Entrepreneurs Program. In partnership with ScaleHealth, the BrightEdge Entrepreneurs program helps founders transform promising cancer-care innovations into scalable, real-world solutions.
The program brings together two specialized tracks serving companies at different points in the innovation journey:
● Digital Health: A 6-month program for companies developing technology-enabled solutions that reduce barriers and improve access to timely, high-quality cancer care.
● Life Sciences: A 10-month program supporting the translation and commercialization of therapeutic, diagnostic, and medical-device innovations that can advance cancer research and patient care.
Through financial investment, mentorship, education and connections to the American Cancer Society and ScaleHealth ecosystems, the program is designed to help founders move innovations from development toward meaningful patient impact.
"Innovation in cancer care requires more than a promising idea or technology, it requires the right expertise, resources and relationships to bring that idea into the lives of patients," said Steve Curtis, Interim Managing Director, BrightEdge. "The BrightEdge Entrepreneurs Program gives mission-driven founders the support they need to build sustainable companies while advancing solutions that can improve cancer prevention, detection, treatment and survivorship."
More on S For Story
Two Tracks Supporting Distinct Innovation Needs
The Digital Health Track seeks cancer-focused startups developing commercially viable and scalable technology solutions that can improve access, quality of life, or outcomes in cancer care. Encompassing all social drivers of health, such as transportation, financial security, and mental wellbeing, as well as direct patient care, these solutions enable access to high-quality, timely care.
Digital Health applicants should demonstrate technical feasibility, evidence of market validation and the potential to produce a measurable impact aligned with the American Cancer Society's mission. Selected companies will be eligible for a $50,000 investment, along with tailored mentorship, industry education and exposure to healthcare leaders and investors.
The Life Sciences Track supports innovators commercializing cancer-focused therapeutics, diagnostics and medical devices. It is particularly suited to technical experts embarking on their first entrepreneurial journey and committed to translating research discoveries into patient-focused companies.
Applicants to this program track do not need to have an incorporated company at the time of application. However, a company must be formed and an option or license to the underlying technology secured before the program begins. Selected Life Sciences companies will be eligible for a $100,000 investment and will receive expert-led education, individualized mentorship, stakeholder engagement and opportunities to present to curated investors.
"ScaleHealth helps connect emerging healthcare companies with the people, knowledge and opportunities required to develop, evaluate and adopt meaningful innovations," said Taylor McPartland, CEO, ScaleHealth. "Together with BrightEdge, we are creating a pathway for exceptional founders to strengthen their companies and accelerate solutions that can make a measurable difference in cancer care."
More on S For Story
Application Dates
Applications for both tracks open September 8, 2026.
● Life Sciences Track application deadline: November 2, 2026
● Digital Health Track application deadline: November 30, 2026
● Acceptance notifications and cohort announcements: February 2027 for the Life Sciences cohort and March 2027 for the Digital Health cohort.
Prospective applicants and ecosystem partners are also invited to attend "Your Guide to the BrightEdge Entrepreneurs Program," an informational webinar on Wednesday, October 7, 2026, at 9:00 a.m. PT / 12:00 p.m. ET.
The webinar will cover program eligibility, investment terms, evaluation considerations, application requirements and key deadlines. Attendees will also have an opportunity to ask questions of program leaders from BrightEdge and ScaleHealth.
To learn more and apply, visit the BrightEdge Entrepreneurs Program landing page
To register for the October 7th informational webinar, visit the webinar registration page.
About BrightEdge
BrightEdge is the innovation and impact-investment arm of the American Cancer Society. Operating at the intersection of investment and innovation, BrightEdge uses the American Cancer Society's legacy in cancer research and patient support to identify and invest in actionable, scalable solutions addressing critical unmet needs across the cancer-care continuum. Its work seeks to advance science, reduce disparities and generate sustainable impact in support of the American Cancer Society's mission. Learn more at acsbrightedge.org.
About ScaleHealth
ScaleHealth connects emerging health-technology companies with healthcare organizations, decision-makers and industry resources to help innovations develop, demonstrate value and achieve adoption. Through its marketplace, programs and advisory services, ScaleHealth supports healthcare innovators in evaluating solutions, strengthening commercialization strategies and building connections across the healthcare ecosystem. Learn more at scalehealth.com.
BrightEdge, the impact investment and innovation arm of the American Cancer Society (ACS), is proud to announce the opening of applications for the 2027 BrightEdge Entrepreneurs Program. In partnership with ScaleHealth, the BrightEdge Entrepreneurs program helps founders transform promising cancer-care innovations into scalable, real-world solutions.
The program brings together two specialized tracks serving companies at different points in the innovation journey:
● Digital Health: A 6-month program for companies developing technology-enabled solutions that reduce barriers and improve access to timely, high-quality cancer care.
● Life Sciences: A 10-month program supporting the translation and commercialization of therapeutic, diagnostic, and medical-device innovations that can advance cancer research and patient care.
Through financial investment, mentorship, education and connections to the American Cancer Society and ScaleHealth ecosystems, the program is designed to help founders move innovations from development toward meaningful patient impact.
"Innovation in cancer care requires more than a promising idea or technology, it requires the right expertise, resources and relationships to bring that idea into the lives of patients," said Steve Curtis, Interim Managing Director, BrightEdge. "The BrightEdge Entrepreneurs Program gives mission-driven founders the support they need to build sustainable companies while advancing solutions that can improve cancer prevention, detection, treatment and survivorship."
More on S For Story
- Jenn Bouchard receives national recognition through the NYC BIG BOOK AWARD®!
- Impact & Influence April 2026: Joel Rodriguez Tirado on Renewal,Growth & Uncomfortable Conversations
- Impact & Influence March 2026: Joel Rodriguez Tirado - Why You're Still Waiting & The Power of Start
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Texas Author T. Dianell Johnson Releases ZANA, a Novel Inspired by a Forgotten East Texas Community
Two Tracks Supporting Distinct Innovation Needs
The Digital Health Track seeks cancer-focused startups developing commercially viable and scalable technology solutions that can improve access, quality of life, or outcomes in cancer care. Encompassing all social drivers of health, such as transportation, financial security, and mental wellbeing, as well as direct patient care, these solutions enable access to high-quality, timely care.
Digital Health applicants should demonstrate technical feasibility, evidence of market validation and the potential to produce a measurable impact aligned with the American Cancer Society's mission. Selected companies will be eligible for a $50,000 investment, along with tailored mentorship, industry education and exposure to healthcare leaders and investors.
The Life Sciences Track supports innovators commercializing cancer-focused therapeutics, diagnostics and medical devices. It is particularly suited to technical experts embarking on their first entrepreneurial journey and committed to translating research discoveries into patient-focused companies.
Applicants to this program track do not need to have an incorporated company at the time of application. However, a company must be formed and an option or license to the underlying technology secured before the program begins. Selected Life Sciences companies will be eligible for a $100,000 investment and will receive expert-led education, individualized mentorship, stakeholder engagement and opportunities to present to curated investors.
"ScaleHealth helps connect emerging healthcare companies with the people, knowledge and opportunities required to develop, evaluate and adopt meaningful innovations," said Taylor McPartland, CEO, ScaleHealth. "Together with BrightEdge, we are creating a pathway for exceptional founders to strengthen their companies and accelerate solutions that can make a measurable difference in cancer care."
More on S For Story
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Nancy Pirri Releases New Contemporary Fake Fiancé Romance Novel - Play Along, Sweetheart
- Mr. Milton Collier Releases New Book: Who's The Best Middleman?
- Wordeee Publishes Beyond Control, Extraordinary Story of John Gano's Life
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
Application Dates
Applications for both tracks open September 8, 2026.
● Life Sciences Track application deadline: November 2, 2026
● Digital Health Track application deadline: November 30, 2026
● Acceptance notifications and cohort announcements: February 2027 for the Life Sciences cohort and March 2027 for the Digital Health cohort.
Prospective applicants and ecosystem partners are also invited to attend "Your Guide to the BrightEdge Entrepreneurs Program," an informational webinar on Wednesday, October 7, 2026, at 9:00 a.m. PT / 12:00 p.m. ET.
The webinar will cover program eligibility, investment terms, evaluation considerations, application requirements and key deadlines. Attendees will also have an opportunity to ask questions of program leaders from BrightEdge and ScaleHealth.
To learn more and apply, visit the BrightEdge Entrepreneurs Program landing page
To register for the October 7th informational webinar, visit the webinar registration page.
About BrightEdge
BrightEdge is the innovation and impact-investment arm of the American Cancer Society. Operating at the intersection of investment and innovation, BrightEdge uses the American Cancer Society's legacy in cancer research and patient support to identify and invest in actionable, scalable solutions addressing critical unmet needs across the cancer-care continuum. Its work seeks to advance science, reduce disparities and generate sustainable impact in support of the American Cancer Society's mission. Learn more at acsbrightedge.org.
About ScaleHealth
ScaleHealth connects emerging health-technology companies with healthcare organizations, decision-makers and industry resources to help innovations develop, demonstrate value and achieve adoption. Through its marketplace, programs and advisory services, ScaleHealth supports healthcare innovators in evaluating solutions, strengthening commercialization strategies and building connections across the healthcare ecosystem. Learn more at scalehealth.com.
Source: ScaleHealth
0 Comments
Latest on S For Story
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
- Tales of Wonder and Dread Celebrates Anniversary with a Classic
- Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
- ChargeOn Announces Conversational Payment Management Solution
- King Larry Steps Into His Moment With Music, Major Performances and a Story Built on Persistence
- New from Regal House, Uprooted, building a farm in a memoir of trauma, resilience, and becoming
- "The Keys to the Kingdom: An Illustrated Timeline of the KC Chiefs" Available Now!
- New Children's Book Celebrates Kindness, Courage and the Power of Following Your Dreams
- Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center
- Sun Gate Golf Retirement Community Doesn't have a Shuffleboard. It Solves Murder Mysteries
- Howling on Paper, Singer-Songwriter Steven Alvarado's First Book, Is Out Now
- New Book Release Cases From Suite 704
- Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
- As Canada and America Turn on Each Other, These Two Authors Stay On Speaking Terms
- History Matters - The Treaty of Paris, 1783
- Enduring Faith Press Launches Domestic Violence Awareness Campaign for When She Chose Life
- Baltimore Mystery Series The Scheme Debuts as Audiobook, Narrated in Author's Own AI-Cloned Vo